This content cannot be displayed.
Toll-Free Helpline
(800) 532-7667
Search
Get MS Updates
Información en Español
Donate
Skip main navigation
MS Information
MS Overview & Glossary
Newly Diagnosed
Symptoms
Treatments
COVID-19 and MS
Patient Support Programs
Clinical Trials Search
Publications
Latest News from MSAA
Videos and Webinars
Podcasts from MSAA
Toll-free Helpline & Chat
Información en Español
MS FAQs and Glossary
How MSAA Can Help
Toll-free Helpline & Chat
Publications
Videos and Webinars
Cooling Products
Equipment Products
MRI Access Program
Educational Programs
Shared Decision-Making Tools
Overall Wellness
Online Aquatic Center
FAQs
Living with MS
My MSAA Community
MS Conversations Blog
Multiple Sclerosis Implementation Network
™
(MSIN
™
)
My MS Journey
My MS Manager™ Mobile App
MS Relapse Resource Center
Overall Wellness
Online Aquatic Center
Educational Programs
Donate
Make A Donation
Honor and Memorial Donations
Become a Monthly Improver
Planned Giving
Other Ways to Give
Donor-Advised Funds
Vehicle Donation
Matching Gifts
Shop & Support MSAA
Donation FAQs
Get Involved
Special Events
Art Showcase
Do-It-Yourself Fundraiser
Multiple Sclerosis Implementation Network
™
(MSIN
™
)
Partnerships
Volunteer With MSAA
FAQ
Calendar
About MSAA
Mission and Overview
MS Awareness Month
MSAA Achievements
Contact Us
Board of Directors
Healthcare Advisory Council
African American Advisory Board
Hispanic/Latinx Advisory Board
MSAA Strategic Plan
Navigating MS
MS Coalition
Annual Report
Financial Information
Search
Type of MS treating:
Secondary-progressive MS (active)
Mayzent®
Read News Article
Mavenclad®
Read News Article
Lemtrada®
Read News Article
Kesimpta®
Read News Article
Gilenya®
Read News Article
Copaxone®
Read News Article
Betaseron®
Read News Article
Bafiertam®
Read News Article
Avonex®
Read News Article
Aubagio®
Read News Article
Posts pagination
Previous
1
2
×